These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16380622)

  • 41. Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.
    Lin JJ; Lu CS; Tsai CH
    J Neurol; 2018 Mar; 265(3):478-485. PubMed ID: 29290055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease.
    Scherfler C; Seppi K; Donnemiller E; Goebel G; Brenneis C; Virgolini I; Wenning GK; Poewe W
    Brain; 2005 Jul; 128(Pt 7):1605-12. PubMed ID: 15817519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.
    Marshall VL; Patterson J; Hadley DM; Grosset KA; Grosset DG
    Nucl Med Commun; 2006 Dec; 27(12):933-7. PubMed ID: 17088677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
    Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
    Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).
    Tackenberg B; Metz A; Unger M; Schimke N; Passow S; Hoeffken H; Hoffmann GF; Müller U; Nolte D; Oertel WH; Eggert K; Möller JC
    Mov Disord; 2007 Apr; 22(6):900-2. PubMed ID: 17377924
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of long-term treatment with pramipexole or levodopa on presynaptic markers assessed by longitudinal [123I]FP-CIT SPECT and histochemistry.
    Depboylu C; Maurer L; Matusch A; Hermanns G; Windolph A; Béhé M; Oertel WH; Höglinger GU
    Neuroimage; 2013 Oct; 79():191-200. PubMed ID: 23631981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.
    Kaasinen V; Vahlberg T
    Ann Neurol; 2017 Dec; 82(6):873-882. PubMed ID: 29165839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Nuclear neuroimaging of dopamine transporter in Parkinsonism--role in routine clinical practice].
    Cohenpour M; Golan H
    Harefuah; 2007 Sep; 146(9):698-702, 733. PubMed ID: 17969308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Striatal dopamine transporter abnormalities associated with midbrain hemiatrophy.
    Nakajima N; Ueda M
    J Neurol Sci; 2019 Apr; 399():94-96. PubMed ID: 30782529
    [No Abstract]   [Full Text] [Related]  

  • 50. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
    Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
    Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: a SPECT follow-up study.
    Ceravolo R; Rossi C; Cilia R; Tognoni G; Antonini A; Volterrani D; Bonuccelli U
    Parkinsonism Relat Disord; 2013 May; 19(5):557-9. PubMed ID: 23433820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease.
    Saarinen EK; Kuusimäki T; Lindholm K; Niemi K; Honkanen EA; Noponen T; Seppänen M; Ihalainen T; Murtomäki K; Mertsalmi T; Jaakkola E; Myller E; Eklund M; Nuuttila S; Levo R; Chaudhuri KR; Antonini A; Vahlberg T; Lehtonen M; Joutsa J; Scheperjans F; Kaasinen V
    Ann Neurol; 2024 Aug; 96(2):262-275. PubMed ID: 38767012
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine transporter binding in Wilson's disease.
    Huang CC; Chu NS; Yen TC; Wai YY; Lu CS
    Can J Neurol Sci; 2003 May; 30(2):163-7. PubMed ID: 12774959
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification analysis of 123I-IPT single photon emission computed tomography uptake in the striatum of parkinsonism with the standard magnetic resonance template.
    Juh R; Pae CU; Lee CU; Kim J; Moon D; Suh T; Choe B
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):18-28. PubMed ID: 16472355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study.
    Pellecchia MT; Varrone A; Annesi G; Amboni M; Cicarelli G; Sansone V; Annesi F; Rocca FE; Vitale C; Pappatà S; Quattrone A; Barone P
    Mov Disord; 2007 Mar; 22(4):559-63. PubMed ID: 17149727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.
    Lynch DR; Mozley PD; Sokol S; Maas NM; Balcer LJ; Siderowf AD
    Mov Disord; 2003 Jul; 18(7):804-12. PubMed ID: 12815660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mixed tremors with integrity of nigrostriatal system: a clinical and DAT-SPECT follow-up study.
    Arabia G; Novellino F; Morelli M; Paglionico S; Salsone M; Giofrè L; Pucci F; Bagnato A; Cascini GL; Nicoletti G; Messina D; Quattrone A
    Mov Disord; 2010 Apr; 25(5):662-4. PubMed ID: 20108366
    [No Abstract]   [Full Text] [Related]  

  • 59. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease.
    Winogrodzka A; Bergmans P; Booij J; van Royen EA; Janssen AG; Wolters EC
    J Neural Transm (Vienna); 2001; 108(8-9):1011-9. PubMed ID: 11716136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.